Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Invested Capital: 2022-2025

Historic Invested Capital for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $343.5 million.

  • Praxis Precision Medicines' Invested Capital fell 10.23% to $343.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.5 million, marking a year-over-year decrease of 10.23%. This contributed to the annual value of $445.4 million for FY2024, which is 539.38% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Invested Capital stood at $343.5 million for Q3 2025, which was down 15.02% from $404.2 million recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Invested Capital peaked at $445.4 million during Q4 2024, and registered a low of $64.5 million during Q1 2023.
  • Over the past 3 years, Praxis Precision Medicines' median Invested Capital value was $343.5 million (recorded in 2025), while the average stood at $271.9 million.
  • As far as peak fluctuations go, Praxis Precision Medicines' Invested Capital plummeted by 66.25% in 2023, and later surged by 539.38% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Invested Capital (Quarterly) stood at $76.1 million in 2022, then fell by 8.46% to $69.7 million in 2023, then spiked by 539.38% to $445.4 million in 2024, then dropped by 10.23% to $343.5 million in 2025.
  • Its Invested Capital was $343.5 million in Q3 2025, compared to $404.2 million in Q2 2025 and $439.2 million in Q1 2025.